Boric Acid
Natural health product licensed in Canada
- Other names
- Boric Acid Vaginal Suppository
- Licence holder
- pH-D Feminine Health, LLC
- NPN or DIN-HM
- 80112108
- Status
- Active licence
- Licence date
- 15 August 2021
- Revision date
- 17 February 2026
- Form
- Suppositoire
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| acide borique Source : Acide borique | 600 mg |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes adultes | minimum: 19 years | 1 suppositoire | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the overgrowth of recurrent or resistant vaginal yeast.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80112108
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.